StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Monday morning. The brokerage issued a hold rating on the stock.
China Pharma Price Performance
NYSE CPHI opened at $0.26 on Monday. China Pharma has a one year low of $0.24 and a one year high of $1.95. The company has a 50-day simple moving average of $0.29 and a 200-day simple moving average of $0.38. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) earnings per share for the quarter. The firm had revenue of $1.37 million during the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- How to Invest in Small Cap Stocks
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Energy and Oil Stocks Explained
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Stock Average Calculator
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
